Human Immunodeficiency Virus  >>  Mifeprex (mifepristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
NCT00352911: Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

Completed
2
19
US
VGX-410 (Mifepristone), Mifeprex, Placebo for VGX-410 (Mifepristone)
VGX Pharmaceuticals, LLC
HIV Infections
06/07
11/07

Download Options